Increased levels of NF-κB inhibitors (IκBα and IκBγ) in the intestinal mucosa of Crohn's disease patients during infliximab treatment, Guidi, L., Costanzo Mario, Ciarniello M., De Vitis I., Pioli Claudio, Gatta L., Pace L., Tricerri A., Bartoloni C., Coppola L., et al. , International Journal of Immunopathology and Pharmacology, Volume 18, Number 1, p.155-164, (2005)

CTLA-4 engagement inhibits Th2 but not Th1 cell polarisation, Ubaldi, V., Gatta L., Pace L., Doria G., and Pioli Claudio , Clinical and Developmental Immunology, Volume 10, Number 1, p.13-17, (2003)